JP2013520977A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520977A5
JP2013520977A5 JP2012555424A JP2012555424A JP2013520977A5 JP 2013520977 A5 JP2013520977 A5 JP 2013520977A5 JP 2012555424 A JP2012555424 A JP 2012555424A JP 2012555424 A JP2012555424 A JP 2012555424A JP 2013520977 A5 JP2013520977 A5 JP 2013520977A5
Authority
JP
Japan
Prior art keywords
parvovirus
recombinant
attenuated
capsid protein
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012555424A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520977A (ja
JP6200155B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/053164 external-priority patent/WO2011107534A1/en
Publication of JP2013520977A publication Critical patent/JP2013520977A/ja
Publication of JP2013520977A5 publication Critical patent/JP2013520977A5/ja
Application granted granted Critical
Publication of JP6200155B2 publication Critical patent/JP6200155B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012555424A 2010-03-05 2011-03-03 組換え弱毒化パルボウイルス Active JP6200155B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31103210P 2010-03-05 2010-03-05
US61/311,032 2010-03-05
EP10155646.2 2010-03-05
EP10155646 2010-03-05
PCT/EP2011/053164 WO2011107534A1 (en) 2010-03-05 2011-03-03 Recombinant attenuated parvovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015200216A Division JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス

Publications (3)

Publication Number Publication Date
JP2013520977A JP2013520977A (ja) 2013-06-10
JP2013520977A5 true JP2013520977A5 (enExample) 2013-11-07
JP6200155B2 JP6200155B2 (ja) 2017-09-20

Family

ID=42562704

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012555424A Active JP6200155B2 (ja) 2010-03-05 2011-03-03 組換え弱毒化パルボウイルス
JP2015200216A Active JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス
JP2018072318A Pending JP2018134088A (ja) 2010-03-05 2018-04-04 組換え弱毒化パルボウイルス

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015200216A Active JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス
JP2018072318A Pending JP2018134088A (ja) 2010-03-05 2018-04-04 組換え弱毒化パルボウイルス

Country Status (10)

Country Link
US (1) US9234182B2 (enExample)
EP (1) EP2542260B1 (enExample)
JP (3) JP6200155B2 (enExample)
CN (1) CN102791288B (enExample)
AU (1) AU2011222910B2 (enExample)
CA (1) CA2790653C (enExample)
DK (1) DK2542260T3 (enExample)
ES (1) ES2566033T3 (enExample)
RU (1) RU2527157C2 (enExample)
WO (1) WO2011107534A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102791288B (zh) * 2010-03-05 2015-02-18 英特维特国际股份有限公司 重组的减毒细小病毒
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
US20140234354A1 (en) * 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
CN105263953B (zh) * 2014-01-15 2020-01-07 勃林格殷格翰动物保健美国有限公司 猪细小病毒5a、使用方法及疫苗
ES2771850T3 (es) 2014-04-17 2020-07-07 Intervet Int Bv Parvovirus porcino
PT3534945T (pt) 2016-11-03 2025-06-30 Boehringer Ingelheim Vetmedica Gmbh Vacina contra o parvovírus suíno
MX380632B (es) 2016-11-03 2025-03-12 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra el parvovirus porcino y el virus del síndrome respiratorio y reproductivo porcino y métodos de producción de esta.
US20230405110A1 (en) 2020-11-04 2023-12-21 Intervet, Inc. Canine Parvovirus
CN114957406B (zh) * 2022-05-26 2024-02-02 吉林大学 一种犬细小病毒的三价抗原和三价病毒样颗粒以及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
CA2348382C (en) * 1998-11-10 2013-09-17 The University Of North Carolina At Chapel Hill Chimeric parvovirus vectors and methods of making and administering the same
CN101563096A (zh) * 2005-07-28 2009-10-21 辉瑞产品公司 疫苗施用方法、新猫杯状病毒、及抗猫细小病毒和猫疱疹病毒的动物免疫方法
NZ614571A (en) * 2007-06-14 2014-12-24 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
CN102791288B (zh) * 2010-03-05 2015-02-18 英特维特国际股份有限公司 重组的减毒细小病毒

Similar Documents

Publication Publication Date Title
JP2013520977A5 (enExample)
RU2012142309A (ru) Рекомбинантный аттенуированный парвовирус
MX372992B (es) Vector de virus adeno-asociado.
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
JP2019530466A5 (enExample)
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
WO2013049121A3 (en) Recombinant phage and methods
ES2623149T3 (es) Parvovirus atenuado vivo
JP2011182797A5 (enExample)
HRP20201324T1 (hr) Vektori aav koji sadrže faktor viii koji kodira gen
EA201692359A1 (ru) Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
WO2011153351A3 (en) Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
WO2010118188A3 (en) Production of an intact virus in a non-host cell system using a secondary host viral construct
JP2015517304A5 (enExample)
WO2010118205A3 (en) Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
ZA202100386B (en) Influenza virus hemagglutinin mutants
RU2014116371A (ru) Повышение выхода вирусоподобных частиц в растениях
TR201904215T4 (tr) Bakteriyel yapay kromozomlar.
CN104561092A (zh) 表达猪瘟病毒e2蛋白重组prrs病毒基因工程疫苗的构建方法和应用
CL2008003821A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado
CN104911152B (zh) 一株重组传染性造血器官坏死病毒rIHNV HLJ‑09株及其构建方法和应用
CN106755089A (zh) 表达山羊淋巴细胞活化分子的细胞系及其构建方法与应用
JP2013531967A5 (enExample)
RU2014129220A (ru) Новый аттенуированный полиовирус: pv-1 mono-cre-x
JP2014502508A5 (enExample)